Discounted Cash Flow
Opko Health, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $1.2b | $-25.1m | $17.6m | -2.1% | $-0.05 |
| 2017 | $1.1b (-12.6%) | $-308.9m (-1131.4%) | $-101.7m (-677.1%) | -28.9% (-1309.2%) | $-0.55 (-1000.0%) |
| 2018 | $990.3m (-7.2%) | $-153.0m (50.5%) | $-110.1m (-8.3%) | -15.5% (46.6%) | $-0.27 (50.9%) |
| 2019 | $901.9m (-8.9%) | $-314.9m (-105.8%) | $-173.7m (-57.7%) | -34.9% (-125.9%) | $-0.53 (-96.3%) |
| 2020 | $1.4b (59.1%) | $30.6m (109.7%) | $39.5m (122.7%) | 2.1% (106.1%) | $0.05 (109.4%) |
| 2021 | $1.8b (23.6%) | $-30.1m (-198.6%) | $36.3m (-8.0%) | -1.7% (-179.7%) | $-0.05 (-200.0%) |
| 2022 | $1.0b (-43.4%) | $-328.4m (-989.5%) | $-95.2m (-362.0%) | -32.7% (-1825.5%) | $-0.46 (-820.0%) |
| 2023 | $863.5m (-14.0%) | $-188.9m (42.5%) | $-33.2m (65.1%) | -21.9% (33.1%) | $-0.25 (45.7%) |
| 2024 | $713.1m (-17.4%) | $-53.2m (71.8%) | $-183.5m (-452.7%) | -7.5% (65.9%) | $-0.08 (68.0%) |
| 2025 | $606.9m (-14.9%) | $-225.7m (-324.0%) | $-190.8m (-4.0%) | -37.2% (-398.3%) | $-0.30 (-275.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.